E J Arts
Overview
Explore the profile of E J Arts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
810
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zuanazzi D, Arts E, Jorge P, Mulyar Y, Gibson R, Xiao Y, et al.
J Dent Res
. 2017 Aug;
96(10):1078-1084.
PMID: 28825520
We explored the potential to diagnose Zika virus (ZIKV) infection by analyzing peptides in saliva during a convalescent phase of infection, long after resolution of acute disease. A 25-y-old woman...
2.
Christie N, Willer D, Lobritz M, Chan J, Arts E, Ostrowski M, et al.
Virology
. 2009 Apr;
388(1):137-46.
PMID: 19368950
Cytotoxic T-lymphocyte (CTL) epitopes within the HIV genome are subject to negative and positive selective pressures, the balance of which influences CTL escape at a given epitope. We investigated whether...
3.
Arts E, Quinones-Mateu M, Albright J
Drug Resist Updat
. 2006 Nov;
1(1):21-8.
PMID: 17092793
Even with the development of novel nucleoside analog inhibitors, zidovudine (AZT or 3'-azido-3'-deoxythymidine) remains a potent and frequently prescribed antiretroviral therapy for HIV-positive individuals. Failure of AZT in monotherapy due...
4.
Quinones-Mateu M, Arts E
Curr Top Microbiol Immunol
. 2006 Mar;
299:83-140.
PMID: 16568897
Viral fitness has been broadly studied during the past three decades, mainly to test evolutionary models and population theories difficult to analyze and interpret with more complex organisms. More recent...
5.
Marozsan A, Torre V, Johnson M, Ball S, Cross J, Templeton D, et al.
J Virol
. 2001 Aug;
75(18):8624-38.
PMID: 11507208
Aminooxypentane (AOP)-RANTES is a potent inhibitor of nonsyncytium-inducing (NSI), CCR5-tropic (R5) human immunodeficiency virus type 1 (HIV-1) isolates. Although classical chemotactic responses are not induced in primary leukocytes by AOP-RANTES,...
6.
Abraha A, Quinones-Mateu M, Mas A, Camarasa M, Arts E
J Biol Chem
. 2001 May;
276(29):27470-9.
PMID: 11353775
Human immunodeficiency virus (HIV)-1 strains have been divided into three groups: main (M), outlier (O), and non-M non-O (N). Biochemical analyses of HIV-1 reverse transcriptase (RT) have been performed predominantly...
7.
Collins K, Mayanja-Kizza H, Sullivan B, Quinones-Mateu M, Toossi Z, Arts E
J Acquir Immune Defic Syndr
. 2000 Oct;
24(5):408-17.
PMID: 11035611
Objective: A continual increase in intrapatient HIV-1 heterogeneity is thought to contribute to evasion of host immune response and eventual progression to AIDS. Tuberculosis (TB) is diagnosed both early and...
8.
Quinones-Mateu M, Ball S, Marozsan A, Torre V, Albright J, Vanham G, et al.
J Virol
. 2000 Sep;
74(19):9222-33.
PMID: 10982369
This study was designed to examine the impact of human immunodeficiency virus type 1 (HIV-1) fitness on disease progression through the use of a dual competition/heteroduplex tracking assay (HTA). Despite...
9.
Torre V, Marozsan A, Albright J, Collins K, Hartley O, Offord R, et al.
J Virol
. 2000 Apr;
74(10):4868-76.
PMID: 10775626
Aminooxypentane (AOP)-RANTES efficiently and specifically blocks entry of non-syncytium-inducing (NSI), CCR5-tropic (R5) human immunodeficiency virus type 1 (HIV-1) into host cells. Inhibition appears to be mediated by increased intracellular retention...
10.
Garcia Lerma J, Soriano V, Mas A, Quinones-Mateu M, Arts E, Heneine W
J Clin Microbiol
. 2000 Jan;
38(1):402-5.
PMID: 10618125
We have evaluated the use of an ultrasensitive reverse transcriptase (RT) activity assay to monitor plasma viremia in two human immunodeficiency virus type 1 (HIV-1) group O-infected patients treated with...